ROSEMARIE SCHMANDT to Biomarkers
This is a "connection" page, showing publications ROSEMARIE SCHMANDT has written about Biomarkers.
Connection Strength
0.030
-
Prospective Randomized Biomarker Study of Metformin and Lifestyle Intervention for Prevention in Obese Women at Increased Risk for Endometrial Cancer. Cancer Prev Res (Phila). 2018 08; 11(8):477-490.
Score: 0.017
-
CGRRF1 as a novel biomarker of tissue response to metformin in the context of obesity. Gynecol Oncol. 2014 Apr; 133(1):83-9.
Score: 0.013